- Home
- About veski
- veski board
- veski innovation fellows
- Timothy Scott
- Benjamin Marsland
- Pierluigi Mancarella
- Vihandha Wickramasinghe
- Jon Shah
- Roger Pocock
- Richard Sandberg
- Colby Zaph
- Kenneth Crozier
- Ethan Goddard-Borger
- Colette McKay
- Luke Connal
- Mark Dawson
- Cameron Simmons
- Tiffany Walsh
- Seth Masters
- Christopher McNeill
- Matthew Call
- Edwin van Leeuwen
- Mark Shackleton
- Ross Dickins
- Ygal Haupt
- Sarah Hosking
- Michael Cowley
- Alyssa Barry
- Gareth Forde
- Marcus Pandy
- Andrew Holmes
- veski fellows
- organisational structure
- veski annual review
- veski impact report
- veski standard
- veski pin
- Contact us
- veski foundation
- Fellowships
- Programs
- News & Events
- News
- Events
- Newsletters
- in conversation
- veski twitter
- veski family in the media
- veski's portraits of innovation
- A banquet of problems to be solved
- A novel approach
- A very special challenge
- At the crossroad of sport and science
- Engineering a better quality of life
- Everything at her fingertips
- Forward propulsion
- Going to the ends of the earth to cure melanoma
- His link to the past and bridge to the future
- Hitting the right note
- Holding up his side of the bargain
- Lighting the way to better child cancer outcomes
- Links and reconnections
- Mining his talent to make a difference
- Putting Melbourne's science on the global stage
- Ready, set, go: the future of locomotion
- Setting his own path
- Springboarding into a slam-dunk for science
- The lens of experience
- Where dreams are made
- veski videos
- People
- veski board
- veski innovation fellows
- Timothy Scott
- Benjamin Marsland
- Pierluigi Mancarella
- Vihandha Wickramasinghe
- Jon Shah
- Roger Pocock
- Richard Sandberg
- Colby Zaph
- Kenneth Crozier
- Ethan Goddard-Borger
- Colette McKay
- Luke Connal
- Mark Dawson
- Cameron Simmons
- Tiffany Walsh
- Seth Masters
- Christopher McNeill
- Matthew Call
- Edwin van Leeuwen
- Mark Shackleton
- Ross Dickins
- Ygal Haupt
- Sarah Hosking
- Michael Cowley
- Alyssa Barry
- Gareth Forde
- Marcus Pandy
- Andrew Holmes
- Victoria Prize recipients
- Victoria Fellows
- veski sustainable agriculture fellows
- inspiring women fellows
- veski connection
- PAHMR recipients
News archive
Carbohydrates may be the key to a better malaria vaccine
Melbourne researchers have shown for the first time that carbohydrates on the surface of malaria parasites play a critical role in malaria’s ability to infect mosquito and human hosts.
The discovery also suggests steps that may improve the only malaria vaccine approved to protect people against Plasmodium falciparum malaria – the most deadly form of the disease.
The research, published today in Nature Communications, was led by Associate Professor Justin Boddey, Dr Ethan Goddard-Borger, Mr Sash Lopaticki and Ms Annie Yang at the Walter and Eliza Hall Institute, with support from Professor Norman Kneteman at the Univeristy of Alberta, Canada.
Associate Professor Boddey said the team had shown that the malaria parasite ‘tags' its proteins with carbohydrates in order to stabilise and transport them, and that this process was crucial to completing the parasite’s lifecycle.
“Malaria parasites have a complex lifecycle that involves constant shapeshifting to evade detection and infect humans and subsequently mosquitoes,” he said.
“We found that the parasite’s ability to ‘tag’ key proteins with carbohydrates is important for two stages of the malaria lifecycle. It is critical for the the earliest stages of human infection, when the parasite migrates through the body and invades in the liver, and later when it is transmitted back to the mosquito from an infected human, enabling the parasite to be spread between people.
“Interfering with the parasite’s ability to attach these carbohydrates to its proteins hinders liver infection and transmission to the mosquito, and weakens the parasite to the point that it cannot survive in the host," Associate Professor Boddey said.
Malaria infects more than 200 million people worldwide each year and kills around 450,000 people, predominantly pregnant women and children. Efforts to eradicate malaria require the development of new therapeutics, particularly an effective malaria vaccine.
The first malaria vaccine approved for human use – RTS,S/AS01 – was approved by European regulators in July 2015 but has not been as successful as hoped, with marginal efficacy that wanes over time.
Dr Goddard-Borger said the research had attracted a lot of interest because of the implications it has for improving malaria vaccine design. “The protein used in the RTS,S vaccine mimics one of the proteins we’ve been studying on the surface of the malaria parasite that is readily recognised by the immune system.
“It was hoped that the vaccine would generate a good antibody response that protected against the parasite, however it has unfortunately not been as effective at evoking protective immunity as hoped. With this study, we’ve shown that the parasite protein is tagged with carbohydrates, making it slightly different to the vaccine, so the antibodies produced may not be optimal for recognising target parasites,” Dr Goddard-Borger said.
Dr Goddard-Borger said there were many documented cases where attaching carbohydrates to a protein improved its efficacy as a vaccine.
“It may be that a version of RTS,S with added carbohydrates will perform better than the current vaccine,” he said. “Now that we know how important these carbohydrates are to the parasite, we can be confident that the malaria parasite cannot ‘escape’ vaccination pressure by doing away with its carbohydrates.”
Dr Boddey said the Institute’s insectary, opened in 2012, was critical to the discovery. “Carbohydrates have long been considered unimportant to malaria parasites. This discovery reveals that carbohydrates are very important, and in two completely different lifecycle stages. This is exciting because to ultimately eradicate malaria we need combined approaches that attack different stages of the parasite at once,” Associate Professor Boddey said.
“This discovery would not have been possible without generous contributions that enabled the construction of a world-class insectary and the recapitulation of the entire human–malaria lifecycle on site in Melbourne. It’s a great pleasure to see this investment paying off with advances that may one day save lives.”
The research was supported by the Australian National Health and Medical Research Council, Australian Research Council, Human Frontiers Science Program, Ramaciotti Foundation, University of Melbourne, veski and Victorian State Government Operational Infrastructure Support Program.
Source: Monash Comprehensive Cancer Consortium
https://mccc.edu.au/news/mpccc-welcomes-new-professor-director-of-oncology-alfred-health-and-monash-university/
veski fellows in the news
14 Jun 2019 | Mercy Hospital for Women
Assoc Prof Natalie Hannan - recognised with two prestigious awards
14 Feb 2019 | Nine Digital Pty Ltd
Prof Michael Cowley launches new weight loss pill in Australia
“Understanding ‘friendly microbes’ may well hold the key to preventing allergic diseases including asthma.”
Professor Benjamin Marsland
Tweets from @veskiorg
Tweets by @veskiorg